Join us - BioInvent

Based in Lund, Ideon Science Park, Sweden, BioInvent has approximately 94 full-time employees. We pride ourselves on providing a supportive team structure and offering numerous opportunities for staff from different departments to work together, sharing knowledge and learning from each other.

Our future as a dynamic organisation is largely dependent on the knowledge, creativity and skills of our employees. As a relatively small organisation, we have an informal and flexible work environment, providing numerous opportunities for professional and personal development.

BioInvent International AB (Nasdaq Stockholm: BINV) is a clinical-stage biotech company that discovers and develops novel and first-in-class immuno-modulatory antibodies for cancer therapy, with currently five drug candidates in six ongoing clinical programs in Phase 1/2 trials for the treatment of hematological cancer and solid tumors, respectively and a fifth program just initiating clinical development. The Company’s validated, proprietary F.I.R.S.T™ technology platform simultaneously identifies both targets and the antibodies that bind to them, generating many promising new drug candidates to fuel the Company’s own clinical development pipeline or for additional licensing and partnering.

The Company generates revenues from research collaborations and license agreements with multiple top-tier pharmaceutical companies, as well as from producing antibodies for third parties in the Company’s fully integrated manufacturing unit. More information is available at . Follow on Twitter: @BioInvent.

Vår framtid som dynamisk organisation är till stor del beroende av våra medarbetares kunskap, kreativitet och kompetens. Som en relativt liten organisation har vi en informell och flexibel arbetsmiljö som ger många möjligheter till professionell och personlig utveckling.